Author:
La Gioia Sara,Seghezzi Michela,Barcella Valeria,Dominoni Paola,Mecca Tommaso,Frigeni Barbara,Conti Marta Zaffira,Vedovello Marcella,Vidali Matteo,Rottoli Mariarosa,Buoro Sabrina
Subject
Neurology (clinical),Neurology,General Medicine
Reference21 articles.
1. The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis;Barnes;Lab. Hematol.,2005
2. Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab;Bonig;Blood,2008
3. McEnroe, R.J., Durham, A.P., Goldford, M.D., et al., 2014. Evaluation of Precision of Quantitative Measurement Procedures – Approved Guideline, third edition. CLSI Guideline EP05-A3E, Wayne, PA.
4. Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study;Bridel;Neurol. Neuroimmunol. Neuroinflamm.,2015
5. Performance evaluation of the Sysmex haematology XN modular system;Briggs;J. Clin. Pathol.,2012
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献